What are you looking for today?

Garnham, Rebecca, Scott, Emma, Livermore, Karen E and Munkley, Jennifer (2019) ST6GAL1: A key player in cancer. Oncology Letters, 18 (2). pp. 211-989. ISSN 1792-1074

Document

Abstract

Abstract

Aberrant glycosylation is a universal feature of cancer cells and there is now overwhelming evidence that glycans can modulate pathways intrinsic to tumour cell biology. Glycans are important in all of the cancer hallmarks and there is a renewed interest in the glycomic profiling of tumours to improve early diagnosis, determine patient prognosis and identify targets for therapeutic intervention. One of the most widely occurring cancer associated changes in glycosylation is abnormal sialylation which is often accompanied by changes in sialyltransferase activity. Several sialyltransferases are implicated in cancer, but in recent years ST6 β-galactoside α-2,6-sialyltransferase 1 (ST6GAL1) has become increasingly dominant in the literature. ST6GAL1 catalyses the addition of α2,6-linked sialic acids to terminal N-glycans and can modify glycoproteins and/or glycolipids. ST6GAL1 is upregulated in numerous types of cancer (including pancreatic, prostate, breast and ovarian cancer) and can promote growth, survival and metastasis. The present review discusses ST6GAL in relation to the hallmarks of cancer, and highlights its key role in multiple mechanisms intrinsic to tumour cell biology.

Item Type: Article
Related URLs:
Depositing User: Rebecca Garnham
URI: https://sure.sunderland.ac.uk/id/eprint/17651

Further Details

More Information

Identifiers

Item ID
17651
Identification Number
ISSN
1792-1074

Users with ORCIDS

Catalogue record

Date Deposited
29 May 2024 09:39
Last Modified
04 Jun 2025 16:17

Contributors

Author
Rebecca Garnham
Author
Emma Scott
Author
Karen E Livermore
Author
Jennifer Munkley

University Divisions

Subjects

Actions (login required)

View Item (Repository Staff Only)

Downloads per month over past year